CFTR and cystic fibrosis: A meta-analysis of four case-control studies in the non-CF population (n = 79 ABPA and 268 controls) showed increased odds of CFTR mutation in the ABPA patients compared to controls (OR 10.39; 95% CI, 4.35–24.79) [140].